Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial.
Saved in:
| Title: | Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. |
|---|---|
| Authors: | Nissen SE (AUTHOR), Nicholls SJ (AUTHOR), Wolski K (AUTHOR), Nesto R (AUTHOR), Kupfer S (AUTHOR), Perez A (AUTHOR), Jure H (AUTHOR), De Larochellière R (AUTHOR), Staniloae CS (AUTHOR), Mavromatis K (AUTHOR), Saw J (AUTHOR), Hu B (AUTHOR), Lincoff AM (AUTHOR), Tuzcu EM (AUTHOR), PERISCOPE Investigators (CORPORATE AUTHOR), Nissen, Steven E1 (AUTHOR), Nicholls, Stephen J (AUTHOR), Wolski, Kathy (AUTHOR), Nesto, Richard (AUTHOR), Kupfer, Stuart (AUTHOR) |
| Source: | JAMA: Journal of the American Medical Association. 4/2/2008, Vol. 299 Issue 13, p1561-1573. 13p. |
| Database: | Academic Search Ultimate |
| ISSN: | 00987484 |
|---|---|
| DOI: | 10.1001/jama.299.13.1561 |
